Concalls & earnings callsShaily Engineering Plastics Limited

Every summarised call, newest first. Latest is Q1 FY27, held 10 Aug 2026.

Latest quarter

Q1 FY27 snapshot

Healthcare, now the largest segment with 85% revenue growth, drove overall performance amid a challenging global environment and softer Consumer demand.

Metric	This quarter	Change
Revenue	₹281 Cr	14%
EBITDA	₹83 Cr	18%
EBITDA Margin	29.7%	120 bps
PAT	₹48 Cr	17%

Latest guidance

Expect to exceed the full-year pen injector guidance of 36 million units.
Additional 25 million pen capacity expected to become operational by end of September.
Gross margin expected to normalize by Q3 FY27.
Consumer business expected to maintain levels similar to FY26, not grow in the current year.
Consumer Electronics revenue projected to reach $10 million within 24 to 30 months (not formal guidance).
Semiconductor Tray revenue to start in Q4 FY27.
Abu Dhabi plant to start commercial sales by end of FY28.

Said on the Q1 FY27 call.

Filed results

Reported quarterly history

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

Quarter	Revenue	Net profit (PAT)	Basic EPS
Q3 FY25	₹197.58 Cr+24.7% YoY+2.9% QoQ	₹25.20 Cr+73.6% YoY+15% QoQ	₹5.49+73.2% YoY+14.9% QoQ
Q2 FY25	₹192.00 Cr+21.9% YoY+7% QoQ	₹21.92 Cr+102.4% YoY+25.9% QoQ	₹4.78-59.5% YoY+25.8% QoQ
Q1 FY25	₹179.39 Cr+14% YoY+5.2% QoQ	₹17.41 Cr+38.2% YoY-10% QoQ	₹3.80-72.3% YoY-10% QoQ
Q4 FY24	₹170.56 Cr+26.8% YoY+7.6% QoQ	₹19.34 Cr+94.8% YoY+33.2% QoQ	₹4.22-61% YoY+33.1% QoQ
Q3 FY24	₹158.44 Cr+16.3% YoY+0.6% QoQ	₹14.52 Cr+156.1% YoY+34.1% QoQ	₹3.17-48.7% YoY-73.1% QoQ

Call history

10 Aug 2026
Q1 FY27Positive tone
Healthcare, now the largest segment with 85% revenue growth, drove overall performance amid a challenging global environment and softer Consumer demand.
Revenue
₹281 Cr14%
EBITDA
₹83 Cr18%
Pharmaceuticals & HealthcareVerified brief7 guidance items